Trial Profile
A study assessing anticoagulant activity of rivaroxaban and dabigatran in patients With nonvalvular atrial fibrillation: A Noninterventional Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Oct 2016
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary) ; Rivaroxaban (Primary)
- Indications Embolism
- Focus Therapeutic Use
- 15 Oct 2016 New trial record